[go: up one dir, main page]

CN103102228A - Preparation method of aryl eneyne compound - Google Patents

Preparation method of aryl eneyne compound Download PDF

Info

Publication number
CN103102228A
CN103102228A CN2012103260463A CN201210326046A CN103102228A CN 103102228 A CN103102228 A CN 103102228A CN 2012103260463 A CN2012103260463 A CN 2012103260463A CN 201210326046 A CN201210326046 A CN 201210326046A CN 103102228 A CN103102228 A CN 103102228A
Authority
CN
China
Prior art keywords
preparation
compound
δppm
cdcl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103260463A
Other languages
Chinese (zh)
Other versions
CN103102228B (en
Inventor
徐华栋
何维杰
蔡茂强
张人伟
郑庆
胡文浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China Normal University
Original Assignee
East China Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China Normal University filed Critical East China Normal University
Priority to CN201210326046.3A priority Critical patent/CN103102228B/en
Publication of CN103102228A publication Critical patent/CN103102228A/en
Application granted granted Critical
Publication of CN103102228B publication Critical patent/CN103102228B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种芳基炔烯化合物的制备方法,以芳基炔类化合物和炔丙醇或炔丙胺类化合物为原料,在有机溶剂条件下,以[Rh(COD)Cl]2与配体作用生成的铑络合物为催化剂,反应制备得到式(I)所示的芳基炔烯化合物。本发明制备方法原料易得,催化剂用量低,高效易于操作,区域选择性好,反应收率较好,实用性强,制备得到的芳基炔烯化合物是一类重要化学合成中间体。The invention discloses a preparation method of an aryl alkyne compound. Using an aryl alkyne compound and a propargyl alcohol or a propargyl amine compound as raw materials, under the condition of an organic solvent, [Rh(COD)Cl] 2 and a compound The rhodium complex compound that body action generates is catalyst, and reaction preparation obtains the aryl alkyne compound shown in formula (I). The preparation method of the invention has easy-to-obtain raw materials, low catalyst consumption, high efficiency and easy operation, good regioselectivity, good reaction yield and strong practicability, and the prepared aryl alkyne compound is a class of important chemical synthesis intermediates.

Description

一种芳基炔烯化合物的制备方法A kind of preparation method of aryl alkyne compound

技术领域 technical field

本发明涉及化合物合成技术领域,具体涉及一种芳基炔烯化合物的制备方法。The invention relates to the technical field of compound synthesis, in particular to a preparation method of an aryl alkyne compound.

背景技术 Background technique

共轭炔烯类化合物是一类非常重要的合成中间体,它是许多天然产物、药物中间体的重要结构单元和合成砌块。目前炔烯类化合物的合成已有文献报道,例如:文献(1)Helio A,Stefani;Marlito Gomes,Jr.Tetrahedron Lett.2005,46,563;(2)K,Sonogashira;Y,Tohda;N,Hagihara.Tetrahedron Lett.1975,16,4467;(3)Hong Mei Peng;Jing Zhao;Xingwei Li.Adv.Synth.Catal.2009,351,1371;(4)H,Katayama;H,Yari;F,Ozawa.Chem.Commun.2005,34,4336(5)M,Nishiura;Z,Hou;T,Miyamoto.J.Am.Chem.Soc.2003,125,1184。现有技术的以上文献报道的合成方法通过金属催化使炔自身二聚或者使炔和烯偶联得到芳基炔烯类化合物。几乎很少有文献或报道提出通过两种末端炔直接交叉氢炔基化制备芳基炔烯化合物的原子经济性的合成方法。Conjugated alkyne compounds are a very important class of synthetic intermediates, which are important structural units and synthetic building blocks of many natural products and pharmaceutical intermediates. At present, the synthesis of acetylenic compounds has been reported in the literature, for example: literature (1) Helio A, Stefani; Marlito Gomes, Jr.Tetrahedron Lett.2005, 46, 563; (2) K, Sonogashira; Y, Tohda; N, Hagihara.Tetrahedron Lett.1975, 16, 4467; (3) Hong Mei Peng; Jing Zhao; Xingwei Li. Adv. Synth. Catal.2009, 351, 1371; (4) H, Katayama; H, Yari; F, Ozawa 2005, 34, 4336(5) M, Nishiura; Z, Hou; T, Miyamoto. J. Am. Chem. Soc. 2003, 125, 1184. The synthesis methods reported in the above literatures of the prior art use metal catalysis to dimerize alkynes or couple alkynes to alkenes to obtain aryl alkyne compounds. Few literatures or reports have proposed an atom-economical synthesis of aryl alkyne compounds via the direct cross-hydrokylation of two terminal alkynes.

发明内容 Contents of the invention

本发明克服现有技术上述缺陷,提供了一种重要的化学合成中间体芳基炔烯化合物的制备方法。The present invention overcomes the above-mentioned defects of the prior art, and provides a preparation method of an important chemical synthesis intermediate aryl alkyne compound.

本发明提出一种芳基炔烯化合物的制备方法,以芳基炔类化合物和炔丙醇或炔丙胺类化合物为原料,以[Rh(COD)Cl]2与配体作用生成的铑络合物为催化剂,在有机溶剂中,反应得到式(I)所示的所述芳基炔烯化合物;The present invention proposes a kind of preparation method of aryl alkyne compound, take aryl alkyne compound and propargyl alcohol or propargyl amine compound as raw material, use [Rh(COD)Cl] 2 and the rhodium complexation that ligand action generates The compound is a catalyst, and in an organic solvent, the reaction obtains the described aryl alkyne compound shown in formula (I);

所述制备方法的反应路线如以下反应式(A)所示:The reaction scheme of described preparation method is shown in following reaction formula (A):

Figure BDA00002102138700011
Figure BDA00002102138700011

其中,R1为氢、甲氧基、甲醛基、硝基、溴、氨基或-NHAc;Wherein, R is hydrogen, methoxy, formaldehyde, nitro, bromine, amino or -NHAc;

R2为-OH或-NHTs。R 2 is -OH or -NHTs.

本发明制备方法得到的产物为如式(I)所示的芳基炔烯化合物,The product obtained by the preparation method of the present invention is an aryl alkyne compound shown in formula (I),

Figure BDA00002102138700012
Figure BDA00002102138700012

式(I)中,R1为氢、甲氧基、甲醛基、硝基、溴、氨基或-NHAc;R2为-OH或-NHTs。In formula (I), R 1 is hydrogen, methoxy, formaldehyde, nitro, bromine, amino or -NHAc; R 2 is -OH or -NHTs.

本发明中,原料芳基炔类化合物结构为:

Figure BDA00002102138700021
R1为:氢,甲氧基,甲醛基,硝基,溴,氨基或-NHAc。原料炔丙醇或炔丙胺类化合物结构为:R2为:-OH或-NHTs。In the present invention, the raw material aryl alkyne compound structure is:
Figure BDA00002102138700021
R 1 is: hydrogen, methoxy, formaldehyde, nitro, bromo, amino or -NHAc. The structure of the raw material propargyl alcohol or propargyl amine compound is: R 2 is: -OH or -NHTs.

本发明中,所述芳基炔类化合物、炔丙醇或炔丙胺类化合物、[Rh(COD)Cl]2、配体的摩尔比为1∶1-1.5∶0.05∶0.2-0.3。优选地,芳基炔类化合物、炔丙醇或炔丙胺类化合物、[Rh(COD)Cl]2、配体的摩尔比为1∶1.5∶0.05∶0.2。In the present invention, the molar ratio of the aryl alkyne compound, propargyl alcohol or propargylamine compound, [Rh(COD)Cl] 2 , and ligand is 1:1-1.5:0.05:0.2-0.3. Preferably, the molar ratio of aryl alkyne compound, propargyl alcohol or propargylamine compound, [Rh(COD)Cl] 2 , and ligand is 1:1.5:0.05:0.2.

本发明中,所述配体是:

Figure BDA00002102138700023
In the present invention, the ligand is:
Figure BDA00002102138700023

优选地,配体是

Figure BDA00002102138700025
Preferably, the ligand is
Figure BDA00002102138700025

本发明中,所述有机溶剂是二氯甲烷、三氯甲烷、四氢呋喃、1,2-二氯乙烷。所述有机溶剂可以使极性或非极性溶剂。In the present invention, the organic solvent is dichloromethane, chloroform, tetrahydrofuran, 1,2-dichloroethane. The organic solvent can be a polar or non-polar solvent.

本发明中,所述反应时间为10-12小时。例如,过夜反应。In the present invention, the reaction time is 10-12 hours. For example, react overnight.

本发明中,所述反应温度为25℃至40℃。优选地,反应温度为40℃。In the present invention, the reaction temperature is from 25°C to 40°C. Preferably, the reaction temperature is 40°C.

本发明制备方法,以芳基炔类化合物和炔丙醇或炔丙胺类化合物为原料,在有机溶剂存在的条件下,以[Rh(COD)Cl]2与配体L作用生成的铑络合物为催化剂,过夜反应制得芳基炔烯化合物。采用本发明方法所得产物经过柱层析方法加以分离。柱层析分离所用的展开剂为极性溶剂与非极性溶剂的混合溶剂,优选地,溶剂可为乙酸乙酯-石油醚,乙酸乙酯-正己烷等混合溶剂,其体积比可以分别是:极性溶剂∶非极性溶剂=1∶2-10。例如:乙酸乙酯∶石油醚=1∶2-10。The preparation method of the present invention uses aryl alkyne compounds and propargyl alcohol or propargyl amine compounds as raw materials, under the condition of the presence of an organic solvent, complexes the rhodium generated by [Rh(COD)Cl] 2 and the ligand L The compound is used as a catalyst, and the aryl alkyne compound is obtained by reacting overnight. The product obtained by adopting the method of the present invention is separated through column chromatography. The developing agent used for column chromatography separation is a mixed solvent of polar solvent and non-polar solvent. Preferably, the solvent can be mixed solvents such as ethyl acetate-petroleum ether, ethyl acetate-n-hexane, etc., and its volume ratio can be respectively : polar solvent: non-polar solvent = 1: 2-10. For example: ethyl acetate:petroleum ether=1:2-10.

本发明研究发现,使用以[Rh(COD)Cl]2与配体L作用生成的铑络合物催化下的交叉氢炔基化反应,可以高偕选择性合成多种偕2-炔基烯丙醇和偕2-炔基烯丙胺类化合物。The present invention found that a variety of gem-2-alkynyl alkenes can be synthesized with high gem-selectivity by using the cross-hydroalkynylation reaction catalyzed by the rhodium complex generated by [Rh(COD)Cl] 2 and the ligand L. Propanol and gem 2-alkynyl allylamines.

现有技术是以某一种炔类化合物自身二聚生成炔烯或者某两种炔类化合物头碰头式偶联生成炔烯化合物。而本发明芳基炔烯化合物的合成方法是采用金属铑络合物催化,创新地提出以Rh(COD)Cl]2与配体L作用生成的铑络合物作为催化剂,使作为原料的两类炔类化合物以头碰尾式生成新的炔烯化合物,实现高的区域选择性。本发明采用原子经济反应制备芳基炔烯化合物,具有催化剂用量低,原料易得,高效易于操作,区域选择性好,产物收率高,实用性强,高效原子经济性,高选择性等优点。本发明制备方法提供的产物是一类重要中间体芳基炔烯化合物。In the prior art, a certain alkyne compound is self-dimerized to form an alkyne compound, or a certain type of alkyne compound is head-to-head coupled to form an alkyne compound. And the synthetic method of aryl alkynene compound of the present invention is to adopt metal rhodium complex to catalyze, innovatively propose to use Rh(COD)Cl] 2 and the rhodium complex that ligand L reacts to generate as catalyzer, make two as raw material Alkyne-like compounds generate new alkyne-alkenes in a head-to-tail manner, achieving high regioselectivity. The present invention adopts atom economical reaction to prepare aryl alkyne compound, which has the advantages of low catalyst consumption, easy to obtain raw materials, high efficiency and easy operation, good regioselectivity, high product yield, strong practicability, efficient atom economy, high selectivity, etc. . The product provided by the preparation method of the invention is a class of important intermediate aryl alkyne compounds.

具体实施方式 Detailed ways

下面结合实施例对本发明作进一步说明。实施本发明的过程、条件、实验方法等,除以下专门提及的内容之外,均为本领域的普遍知识和公知常识,本发明没有特别限制内容。The present invention will be further described below in conjunction with embodiment. The process, conditions, experimental methods, etc. for implementing the present invention, except for the content specifically mentioned below, are common knowledge and common knowledge in this field, and the present invention has no special limitation content.

本发明一种芳基炔烯化合物的制备方法,以芳基炔类化合物和炔丙醇或炔丙胺类化合物为原料,以[Rh(COD)Cl]2与配体作用生成的铑络合物为催化剂,在有机溶剂中,反应得到式(I)所示的所述芳基炔烯化合物;所述制备方法的反应路线如以下式(A)所示,其中,R1为氢、甲氧基、甲醛基、硝基、溴、氨基或-NHAc;R2为-OH或-NHTs。A kind of preparation method of aryl alkyne compound of the present invention, with aryl alkyne compound and propargyl alcohol or propargyl amine compound as raw material, with [Rh (COD) Cl] 2 and the rhodium complex compound that ligand action generates As a catalyst, in an organic solvent, the reaction obtains the aryl alkyne compound shown in formula (I); the reaction scheme of the preparation method is shown in the following formula (A), wherein, R is hydrogen, methoxy Base, formaldehyde, nitro, bromine, amino or -NHAc; R 2 is -OH or -NHTs.

Figure BDA00002102138700031
Figure BDA00002102138700031

反应式(A)Reaction formula (A)

Figure BDA00002102138700032
Figure BDA00002102138700033
优选的配体是
Figure BDA00002102138700034
Figure BDA00002102138700032
Figure BDA00002102138700033
The preferred ligand is
Figure BDA00002102138700034

实施例1:Example 1:

以[Rh(COD)Cl]2与配体形成的金属铑络合物催化制备芳基炔烯化合物的反应,在氩气氛围下向干燥的反应管中加入[Rh(COD)Cl]2和配体,随后依次加入无水二氯甲烷和原料化合物(1),最后用蠕动泵注入原料化合物(2),40℃或室温下过夜反应。反应结束后将反应液过滤浓缩经柱层析分离得产物(乙酸乙酯∶石油醚=1∶2-10,V/V)。反应路线、反应原料、实验条件及产物等如下所列。With [Rh (COD) Cl] 2 and the metal rhodium complex that ligand forms to catalyze the reaction that prepares aryl alkynene compound, add [Rh (COD) Cl] 2 and Ligand, followed by adding anhydrous dichloromethane and raw material compound (1), and finally injecting raw material compound (2) with a peristaltic pump, reacting overnight at 40°C or room temperature. After the reaction, the reaction liquid was concentrated by filtration and separated by column chromatography to obtain the product (ethyl acetate:petroleum ether=1:2-10, V/V). The reaction scheme, reaction raw materials, experimental conditions and products are listed below.

Figure BDA00002102138700041
Figure BDA00002102138700041

Figure BDA00002102138700042
Figure BDA00002102138700042

其中,配体L分别为:

Figure BDA00002102138700051
Figure BDA00002102138700052
Among them, the ligands L are respectively:
Figure BDA00002102138700051
Figure BDA00002102138700052

实施例2:Example 2:

以[Rh(COD)Cl]2与配体形成的金属铑络合物催化制备芳基炔烯化合物的反应,在氩气氛围下向干燥的反应管中加入5mol%[Rh(COD)Cl]2与20mol%PPh3,随后依次加入溶剂和原料化合物(1),最后用蠕动泵注入原料化合物(2),40℃或室温下过夜反应。反应结束后将反应液过滤浓缩经柱层析分离得产物(乙酸乙酯∶石油醚=1∶2-10,V/V)。反应路线、反应原料、优化条件及产物等如下所列。The metal rhodium complex formed by [Rh(COD)Cl] 2 and the ligand is used to catalyze the reaction of preparing aryl alkyne compounds, and 5mol% [Rh(COD)Cl] is added to the dry reaction tube under an argon atmosphere 2 and 20mol% PPh 3 , then add the solvent and the raw material compound (1) sequentially, and finally inject the raw material compound (2) with a peristaltic pump, and react overnight at 40° C. or room temperature. After the reaction, the reaction liquid was concentrated by filtration and separated by column chromatography to obtain the product (ethyl acetate:petroleum ether=1:2-10, V/V). The reaction scheme, reaction raw materials, optimized conditions and products are listed below.

Figure BDA00002102138700053
Figure BDA00002102138700053

Figure BDA00002102138700054
Figure BDA00002102138700054

Figure BDA00002102138700061
Figure BDA00002102138700061

其中,DCM是二氯甲烷,THF是四氢呋喃,DCE是1,2-二氯乙烷。Wherein, DCM is dichloromethane, THF is tetrahydrofuran, and DCE is 1,2-dichloroethane.

实施例3:芳基乙炔和炔丙醇在金属铑络合物催化下制备2-炔基烯丙醇Embodiment 3: Arylacetylene and propargyl alcohol prepare 2-alkynyl allyl alcohol under metal rhodium complex catalysis

Figure BDA00002102138700062
Figure BDA00002102138700062

在氩气氛围下向干燥的反应管中加入[Rh(COD)Cl]2(5mol%)和PPh3(30mol%),随后依次加入1ml无水二氯甲烷和0.5mmol芳基乙炔。最后用蠕动泵注入0.75mmol炔丙醇,40℃下过夜反应。反应结束后将反应液过滤浓缩经柱层析分离得产品(乙酸乙酯∶石油醚=1∶2-10,V/V)。[Rh(COD)Cl] 2 (5 mol%) and PPh 3 (30 mol%) were added to the dry reaction tube under argon atmosphere, followed by 1 ml of anhydrous dichloromethane and 0.5 mmol of aryl acetylene. Finally, 0.75 mmol of propargyl alcohol was injected with a peristaltic pump, and reacted overnight at 40°C. After the reaction, the reaction solution was concentrated by filtration and separated by column chromatography to obtain the product (ethyl acetate:petroleum ether=1:2-10, V/V).

所用原料芳基炔类化合物

Figure BDA00002102138700071
中,R1分别为:氢、甲氧基、甲醛基、硝基、溴、氨基或-NHAc,相应制备得到的产物式(I)芳基炔烯化合物为P1-P10,详见以下所示。Raw material aryl alkynes
Figure BDA00002102138700071
Among them, R1 are respectively: hydrogen, methoxyl group, formaldehyde group, nitro group, bromine, amino group or-NHAc, and the product formula (I) aryl alkynene compound prepared accordingly is P1-P10, see the following for details .

Figure BDA00002102138700072
Figure BDA00002102138700072

收率:70%.1H NMR(500MHz,CDCl3):δppm 7.47-7.45(m,2H),7.33-7.32(m,3H),5.61(d,J=1.2Hz,1H),5.58(s,1H),4.25(d,J=3.1Hz,2H),1.90(bs,1H);13C NMR(100MHz,CDCl3):δppm 131.7,131.2,128.5,128.4,122.8,120.2,90.8,87.0,and 65.3;HRMS(ESI):计算值C11H10O[M+Na]+:181.0624;检测值:181.0623.。Yield: 70%. 1 H NMR (500MHz, CDCl 3 ): δppm 7.47-7.45(m, 2H), 7.33-7.32(m, 3H), 5.61(d, J=1.2Hz, 1H), 5.58(s , 1H), 4.25 (d, J=3.1Hz, 2H), 1.90 (bs, 1H); 13 C NMR (100MHz, CDCl 3 ): δppm 131.7, 131.2, 128.5, 128.4, 122.8, 120.2, 90.8, 87.0, and 65.3; HRMS (ESI): Calcd. for C 11 H 10 O [M+Na] + : 181.0624; Found: 181.0623.

Figure BDA00002102138700073
Figure BDA00002102138700073

收率:55%.1H NMR(500MHz,CDCl3):δppm 7.41(d,J=8.7Hz,2H),6.87(d,J=8.7Hz,2H),5.58(d,J=1.2Hz,1H),5.55(s,1H),4.24(s,2H),3.83(s,3H),1.90(bs,1H);13C NMR(100MHz,CDCl3):δppm 159.8,133.2,119.7,118.4,114.9,114.0,90.6,85.5,65.4,55.2;HRMS(ESI):计算值C12H12O2[M+Na]+:211.0733,检测值:211.0730。Yield: 55%. 1 H NMR (500MHz, CDCl 3 ): δppm 7.41(d, J=8.7Hz, 2H), 6.87(d, J=8.7Hz, 2H), 5.58(d, J=1.2Hz, 1H), 5.55(s, 1H), 4.24(s, 2H), 3.83(s, 3H), 1.90(bs, 1H); 13 C NMR (100MHz, CDCl 3 ): δppm 159.8, 133.2, 119.7, 118.4, 114.9, 114.0, 90.6, 85.5 , 65.4, 55.2; HRMS (ESI ) : Calcd. for C12H12O2 [M+Na] + : 211.0733, found: 211.0730.

Figure BDA00002102138700074
Figure BDA00002102138700074

收率:52%.1H NMR(400MHz,CDCl3):δppm 8.20(d,J=8.4Hz,2H),7.60(d,J=8.8Hz,2H),5.73(s,1H),5.68(s,1H),4.27(s,2H);13C NMR(100MHz,CDCl3):δppm 152.4,132.4,129.7,123.6,122.7,92.2,88.8,65.1.HRMS(ESI):计算值C11H9NO3[M+Na]+:226.0475,检测值:226.0474。Yield: 52%. 1 H NMR (400MHz, CDCl 3 ): δppm 8.20(d, J=8.4Hz, 2H), 7.60(d, J=8.8Hz, 2H), 5.73(s, 1H), 5.68( s, 1H), 4.27 (s, 2H); 13 C NMR (100MHz, CDCl 3 ): δppm 152.4, 132.4, 129.7, 123.6, 122.7, 92.2, 88.8, 65.1. HRMS (ESI): Calculated for C 11 H 9 NO 3 [M+Na] + : 226.0475, detected value: 226.0474.

收率:65%.1H NMR(500MHz,CDCl3):δppm 10.0(s,1H),7.85(d,J=7.5Hz,2H),7.61(d,J=7.5Hz,2H),5.70(s,1H),5.66(s,1H),4.27(s,2H),1.86(bs,1H).13C NMR(125MHz,CDCl3):δppm 191.5,135.5,132.2,130.8,129.5,129.1,122.0,91.0,89.8,65.1.HRMS(ESI):计算值C12H10O2[M+Na]+:209.0573,检测值:209.0571。Yield: 65%. 1 H NMR (500MHz, CDCl 3 ): δppm 10.0(s, 1H), 7.85(d, J=7.5Hz, 2H), 7.61(d, J=7.5Hz, 2H), 5.70( s, 1H), 5.66 (s, 1H), 4.27 (s, 2H), 1.86 (bs, 1H). 13 C NMR (125MHz, CDCl 3 ): δppm 191.5, 135.5, 132.2, 130.8, 129.5, 129.1, 122.0 , 91.0, 89.8, 65.1. HRMS ( ESI ): Calcd. for C12H10O2 [M+Na] + : 209.0573 , found: 209.0571.

收率:88%.1H NMR(500MHz,CDCl3):δppm 7.59(d,J=7.9Hz,1H),7.49(d,J=1.3Hz,1H),7.28(m,1H),7.18(m,1H),5.64(s,2H),4.27(s,2H).13C NMR(100MHz,CDCl3):δppm 133.3,132.4,131.1,129.7,127.1,125.7,124.9,121.1,91.6,89.6,65.2.HRMS(ESI):计算值C11H9BrO[M+Na]+:258.9729,检测值:258.9730。Yield: 88%. 1 H NMR (500MHz, CDCl 3 ): δppm 7.59 (d, J=7.9Hz, 1H), 7.49 (d, J=1.3Hz, 1H), 7.28 (m, 1H), 7.18( m, 1H), 5.64(s, 2H), 4.27(s, 2H). 13 C NMR (100MHz, CDCl 3 ): δppm 133.3, 132.4, 131.1, 129.7, 127.1, 125.7, 124.9, 121.1, 91.6, 89.6, 65.2. HRMS (ESI): Calcd. for C11H9BrO [M+Na] + : 258.9729, found: 258.9730.

Figure BDA00002102138700082
Figure BDA00002102138700082

收率:87%.1H NMR(400MHz,CDCl3):δppm 7.32-7.28(m,1H),7.17-7.13(m,1H),6.77-6.71(m,2H),5.57(m,2H),4.27(s,2H),3.77(br,2H).13C NMR(100MHz,CDCl3):δppm147.9,132.0,131.3,129.9,120.1,118.0,114.5,107.6,92.7,87.6,65.4.HRMS(ESI):计算值C11H11NO[M+Na]+:196.0733,检测值:196.0728。Yield: 87%. 1 H NMR (400MHz, CDCl 3 ): δppm 7.32-7.28(m, 1H), 7.17-7.13(m, 1H), 6.77-6.71(m, 2H), 5.57(m, 2H) , 4.27(s, 2H), 3.77(br, 2H). 13 C NMR (100MHz, CDCl 3 ): δppm 147.9, 132.0, 131.3, 129.9, 120.1, 118.0, 114.5, 107.6, 92.7, 87.6, 65.4. HRMS (ESI): Calcd. for C11H11NO [M+Na] + : 196.0733 , found: 196.0728.

Figure BDA00002102138700083
Figure BDA00002102138700083

收率:65%.1H NMR(500MHz,CDCl3):δppm 7.46-7.44(m,2H),7.32-7.30(m,2H),5.63(s,1H),5.59(s,1H),4.23(s,2H),1.80(br,1H).13C NMR(100MHz,CDCl3):δppm 133.1,131.6,131.0,122.7,121.8,121.0,89.4,88.1,65.2.HRMS(ESI):计算值C11H9BrO[M+Na]+ 258.9729,检测值:258.9729。Yield: 65%. 1 H NMR (500MHz, CDCl 3 ): δppm 7.46-7.44(m, 2H), 7.32-7.30(m, 2H), 5.63(s, 1H), 5.59(s, 1H), 4.23 (s, 2H), 1.80 (br, 1H). 13 C NMR (100MHz, CDCl 3 ): δppm 133.1, 131.6, 131.0, 122.7, 121.8, 121.0, 89.4, 88.1, 65.2. HRMS (ESI): Calculated C 11 H 9 BrO [M+Na] + 258.9729, found: 258.9729.

Figure BDA00002102138700084
Figure BDA00002102138700084

收率:73%.1H NMR(500MHz,CDCl3):δppm 8.41(d,J=8.4Hz,1H),8.23(bs,1H),7.42(d,J=7.6Hz,1H),7.36-7.33(m,1H),7.06-7.03(m,1H),5.60(s,1H),5.59(s,1H),4.31(d,J=3.6Hz,2H),2.35(bs,1H),2.23(s,3H).13C NMR(125MHz,CDCl3):δppm 169.0,139.4,131.2,130.9,123.3,120.9,119.4,111.6,94.5,86.4,65.5,24.6.HRMS(ESI):计算值C13H13NO2[M+Na]+:238.0838,检测值:238.0842。Yield: 73%. 1 H NMR (500MHz, CDCl 3 ): δppm 8.41(d, J=8.4Hz, 1H), 8.23(bs, 1H), 7.42(d, J=7.6Hz, 1H), 7.36- 7.33(m, 1H), 7.06-7.03(m, 1H), 5.60(s, 1H), 5.59(s, 1H), 4.31(d, J=3.6Hz, 2H), 2.35(bs, 1H), 2.23 (s, 3H). 13 C NMR (125MHz, CDCl 3 ): δppm 169.0, 139.4, 131.2, 130.9, 123.3, 120.9, 119.4, 111.6, 94.5, 86.4, 65.5, 24.6. HRMS (ESI): Calculated for C 13 H 13 NO 2 [M+Na] + : 238.0838, detected value: 238.0842.

Figure BDA00002102138700091
Figure BDA00002102138700091

收率:64%.1H NMR(400MHz,CDCl3):δppm 7.60(t,J=1.6Hz,1H),7.46-7.43(m,1H),7.38(d,J=7.7Hz,1H),7.18(t,J=7.9Hz,1H),5.64(d,J=1.4Hz,1H),5.59(d,J=1.4Hz,1H),4.23(s,2H),2.04(bs,1H).13C NMR(100MHz,CDCl3):δppm 134.4,131.6,130.9,130.2,129.8,124.8,122.1,121.3,89.2,88.3,76.7,65.2.HRMS(ESI):计算值C13H13NO2[M+Na]+:258.9729,检测值:258.9727。Yield: 64%. 1 H NMR (400MHz, CDCl 3 ): δppm 7.60(t, J=1.6Hz, 1H), 7.46-7.43(m, 1H), 7.38(d, J=7.7Hz, 1H), 7.18(t, J=7.9Hz, 1H), 5.64(d, J=1.4Hz, 1H), 5.59(d, J=1.4Hz, 1H), 4.23(s, 2H), 2.04(bs, 1H). 13 C NMR (100MHz, CDCl 3 ): δppm 134.4, 131.6, 130.9, 130.2, 129.8, 124.8, 122.1, 121.3, 89.2, 88.3, 76.7, 65.2. HRMS (ESI): Calculated for C 13 H 13 NO 2 [M +Na] + : 258.9729, detected value: 258.9727.

Figure BDA00002102138700092
Figure BDA00002102138700092

收率:42%.1H NMR(500MHz,CDCl3):δppm 8.15(d,J=7.1Hz,1H),7.78(s,1H),7.67(d,J=7.7Hz,1H),7.38-7.35(m,1H),7.32-7.29(m,1H),5.62(s,2H),4.30(s,2H),1.67(s,9H).13CNMR(125MHz,CDCl3):δppm 149.0,131.3,130.2,128.9,125.2,123.2,120.1,119.9,115.2,102.9,90.5,84.4,82.8,65.4,53.4,28.1.HRMS(ESI):计算值320.1257,检测值:320.1293。Yield: 42%. 1 H NMR (500MHz, CDCl 3 ): δppm 8.15(d, J=7.1Hz, 1H), 7.78(s, 1H), 7.67(d, J=7.7Hz, 1H), 7.38- 7.35(m, 1H), 7.32-7.29(m, 1H), 5.62(s, 2H), 4.30(s, 2H), 1.67(s, 9H). 13 CNMR(125MHz, CDCl 3 ): δppm 149.0, 131.3 , 130.2, 128.9, 125.2, 123.2, 120.1, 119.9, 115.2, 102.9, 90.5, 84.4, 82.8, 65.4, 53.4, 28.1. HRMS (ESI): calculated 320.1257, detected: 320.1293.

实施例4:芳基乙炔和炔丙胺在金属铑络合物催化下制备2-炔基烯丙胺Embodiment 4: Arylacetylene and propargylamine prepare 2-alkynyl allylamine under the catalysis of metal rhodium complex

Figure BDA00002102138700093
Figure BDA00002102138700093

其中Ts为对甲苯磺酰基,DCM为二氯甲烷。Wherein Ts is p-toluenesulfonyl, DCM is dichloromethane.

在氩气氛围下向干燥的反应管中加入[Rh(COD)Cl]2(5mol%)和PPh3(30mol%),随后依次加入1ml无水二氯甲烷和0.5mmol芳基乙炔。最后用蠕动泵注入0.75mmol炔丙胺,40℃下过夜反应。反应结束后将反应液过滤浓缩经柱层析分离得产品(乙酸乙酯∶石油醚=1∶2-10,V/V)。[Rh(COD)Cl] 2 (5 mol%) and PPh 3 (30 mol%) were added to the dry reaction tube under argon atmosphere, followed by 1 ml of anhydrous dichloromethane and 0.5 mmol of aryl acetylene. Finally, 0.75 mmol propargylamine was injected with a peristaltic pump, and reacted overnight at 40°C. After the reaction, the reaction solution was concentrated by filtration and separated by column chromatography to obtain the product (ethyl acetate:petroleum ether=1:2-10, V/V).

所用原料芳基炔类化合物中,R1分别为:氢、甲氧基、甲醛基、硝基、溴、氨基或-NHAc,相应制备得到的产物式(I)芳基炔烯化合物分别为P11-P20,详见以下所示。Raw material aryl alkynes Among them, R 1 are respectively: hydrogen, methoxy group, formaldehyde group, nitro group, bromine, amino group or-NHAc, and the product formula (I) aryl alkynene compound prepared accordingly is respectively P11-P20, see the following for details Show.

Figure BDA00002102138700101
Figure BDA00002102138700101

收率:84%.1H NMR(500MHz,CDCl3):δppm 7.79(d,J=5.4Hz,2H),7.38-7.36(m,2H),7.31-7.29(m,3H),7.25(d,J=8.0Hz,2H),5.46(m,2H),5.27(br,1H),3.74(d,J=6.4Hz,2H),2.37(s,3H).13C NMR(100MHz,CDCl3):δppm 143.4,137.3,131.7,129.7,128.6,128.3,127.2,127.1,122.7,122.5,90.9,87.0,47.6,21.4.HRMS(ESI):计算值C18H17NO2S[M+Na]+:334.0872,检测值:334.0910.。Yield: 84%. 1 H NMR (500MHz, CDCl 3 ): δppm 7.79(d, J=5.4Hz, 2H), 7.38-7.36(m, 2H), 7.31-7.29(m, 3H), 7.25(d , J=8.0Hz, 2H), 5.46(m, 2H), 5.27(br, 1H), 3.74(d, J=6.4Hz, 2H), 2.37(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 143.4, 137.3, 131.7, 129.7, 128.6, 128.3, 127.2, 127.1, 122.7, 122.5, 90.9, 87.0, 47.6, 21.4. HRMS (ESI): calculated for C 18 H 17 NO 2 S [M+Na] + : 334.0872, detection value: 334.0910..

Figure BDA00002102138700102
Figure BDA00002102138700102

收率:92%.1H NMR(500MHz,CDCl3):δppm 7.78(d,J=8.2Hz,2H),7.31(d,J=8.7Hz,2H),7.24(d.J=8.1Hz,2H),6.82(d,J=8.6Hz,2H),5.40(s,1H),5.39(s,1H),5.27(br,1H),3.78(s,3H),3.72(d,J=6.4Hz,2H),2.36(s,3H).13C NMR(100MHz,CDCl3):δppm 160.0,143.5,137.3,133.2,132.1,129.7,127.2,121.9,114.6,114.0,91.2,85.8,55.2,47.8,21.4.HRMS(ESI):计算值C19H19NO3S[M+Na]+:364.0978,检测值:364.1000。Yield: 92%. 1 H NMR (500MHz, CDCl 3 ): δppm 7.78 (d, J=8.2Hz, 2H), 7.31 (d, J=8.7Hz, 2H), 7.24 (dJ=8.1Hz, 2H) , 6.82(d, J=8.6Hz, 2H), 5.40(s, 1H), 5.39(s, 1H), 5.27(br, 1H), 3.78(s, 3H), 3.72(d, J=6.4Hz, 2H), 2.36(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 160.0, 143.5, 137.3, 133.2, 132.1, 129.7, 127.2, 121.9, 114.6, 114.0, 91.2, 85.8, 55.2, 47.8, 21.4 .HRMS (ESI): Calcd. for C19H19NO3S [M+Na] + : 364.0978, found : 364.1000.

Figure BDA00002102138700103
Figure BDA00002102138700103

收率:77%.1H NMR(400MHz,CDCl3):δppm 8.10(d,J=8.4Hz,2H),7.71(d,J=8.0Hz,2H),7.46(d,J=8.0Hz,2H),7.22(d,J=8.0Hz,2H),5.50(s,2H),5.07(t,J=6.0Hz,1H),3.7(d,J=6.4Hz,2H),2.33(s,3H).13C NMR(100MHz,CDCl3):δppm 147.2,143.6,137.2,132.4,129.7,129.4,127.1,126.6,124.8,123.6,91.9,89.1,47.5,21.5.HRMS(ESI):计算值C18H16N2O4S[M+Na]+:379.0723,检测值:379.0741。Yield: 77%. 1 H NMR (400MHz, CDCl 3 ): δppm 8.10(d, J=8.4Hz, 2H), 7.71(d, J=8.0Hz, 2H), 7.46(d, J=8.0Hz, 2H), 7.22(d, J=8.0Hz, 2H), 5.50(s, 2H), 5.07(t, J=6.0Hz, 1H), 3.7(d, J=6.4Hz, 2H), 2.33(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 147.2, 143.6, 137.2, 132.4, 129.7, 129.4, 127.1, 126.6, 124.8, 123.6, 91.9, 89.1, 47.5, 21.5. HRMS (ESI): Calculated C 18 H 16 N 2 O 4 S[M+Na] + : 379.0723, detected value: 379.0741.

Figure BDA00002102138700104
Figure BDA00002102138700104

收率:70%.1H NMR(500MHz,CDCl3):δppm 9.97(s,1H),7.79-7.75(m,4H),7.51(d,J=7.9Hz,2H),7.25(d,J=7.9Hz,2H),5.54(s,1H),5.52(s,1H),5.46(br,1H),3.75(d,J=6.4Hz,2H),2.37(s,3H).13C NMR(100MHz,CDCl3):δppm 191.7,143.6,137.3,135.7,132.3,129.8,129.6,128.9,127.2,126.9,124.3,90.9,90.0,47.5,21.4.HRMS(ESI):计算值C19H17NO3S[M+Na]+:362.0861,检测值:362.0864。Yield: 70%. 1 H NMR (500MHz, CDCl 3 ): δppm 9.97(s, 1H), 7.79-7.75(m, 4H), 7.51(d, J=7.9Hz, 2H), 7.25(d, J =7.9Hz, 2H), 5.54(s, 1H), 5.52(s, 1H), 5.46(br, 1H), 3.75(d, J=6.4Hz, 2H), 2.37(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 191.7, 143.6, 137.3, 135.7, 132.3, 129.8, 129.6, 128.9, 127.2, 126.9, 124.3, 90.9, 90.0, 47.5, 21.4. HRMS (ESI): calculated for C 19 H 17 NO 3 S[M+Na] + : 362.0861, detected value: 362.0864.

Figure BDA00002102138700111
Figure BDA00002102138700111

收率:95%.1H NMR(500MHz,CDCl3):δppm 7.78(d,J=8.2Hz,2H),7.56(d,J=8.1Hz,1H),7.39(d,J=6.9Hz,1H),7.23-7.22(m,3H),7.17-7.14(m,1H),5.48(s,2H),5.27(br,1H),3.78(d,J=6.0Hz,2H),2.35(s,3H).13C NMR(100MHz,CDCl3):δppm 143.6,137.2,133.4,132.5,130.0,129.7,127.4,127.2,126.8,125.7,124.6,123.6,91.3,90.0,47.8,21.6.HRMS(ESI):计算值C19H17NO3S[M+Na]+:411.9977,检测值:412.0017。Yield: 95%. 1 H NMR (500MHz, CDCl 3 ): δppm 7.78(d, J=8.2Hz, 2H), 7.56(d, J=8.1Hz, 1H), 7.39(d, J=6.9Hz, 1H), 7.23-7.22(m, 3H), 7.17-7.14(m, 1H), 5.48(s, 2H), 5.27(br, 1H), 3.78(d, J=6.0Hz, 2H), 2.35(s , 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 143.6, 137.2, 133.4, 132.5, 130.0, 129.7, 127.4, 127.2, 126.8, 125.7, 124.6, 123.6, 91.3, 90.0, 47.8, 21.6. HRMS (ESI ): Calcd. for C 19 H 17 NO 3 S[M+Na] + : 411.9977, found: 412.0017.

Figure BDA00002102138700112
Figure BDA00002102138700112

收率:65%.1H NMR(400MHz,CDCl3):δppm 7.69(d,J=8.0Hz,2H),7.17(d,J=8.4Hz,2H),7.13(d,J=8.0Hz,1H),7.05(t,J=7.7Hz,1H),6.61-6.56(m,2H),5.35(s,1H),5.32(s,1H),5.26(br,1H),3.86(s,2H),3.65(d,J=6.4Hz,2H),2.30(s,3H).13C NMR(100MHz,CDCl3):δppm 147.9,143.5,137.1,132.1,130.1,129.7,127.3,127.1,122.4,117.9,114.6,107.3,92.3,88.1,48.1,21.5.HRMS(ESI):计算值C18H18N2O2S[M+Na]+:349.0981,检测值:349.1026。Yield: 65%. 1 H NMR (400MHz, CDCl 3 ): δppm 7.69(d, J=8.0Hz, 2H), 7.17(d, J=8.4Hz, 2H), 7.13(d, J=8.0Hz, 1H), 7.05(t, J=7.7Hz, 1H), 6.61-6.56(m, 2H), 5.35(s, 1H), 5.32(s, 1H), 5.26(br, 1H), 3.86(s, 2H ), 3.65 (d, J=6.4Hz, 2H), 2.30 (s, 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 147.9, 143.5, 137.1, 132.1, 130.1, 129.7, 127.3, 127.1, 122.4, 117.9, 114.6 , 107.3, 92.3 , 88.1 , 48.1, 21.5. HRMS (ESI): Calcd. for C18H18N2O2S [M+Na] + : 349.0981, found: 349.1026.

收率:90%,1H NMR(500MHz,CDCl3):δppm 7.76(d,J=8.0Hz,2H),7.42(d,J=6.8Hz,2H),7.26-7.21(m,4H),5.47(s,1H),5.46(s,1H),5.32(br,1H),3.73(d,J=6.5Hz,2H),2.37(s,3H).13CNMR(100MHz,CDCl3):δppm 143.4,137.2,133.1,132.0,131.6,129.7,127.2,126.9,123.2,122.9,121.5,89.9,88.1,47.6,21.5.HRMS(ESI):计算值C18H16BrNO2S[M+Na]+:411.9977,检测值:412.0024。Yield: 90%, 1 H NMR (500MHz, CDCl 3 ): δppm 7.76 (d, J=8.0Hz, 2H), 7.42 (d, J=6.8Hz, 2H), 7.26-7.21 (m, 4H), 5.47(s, 1H), 5.46(s, 1H), 5.32(br, 1H), 3.73(d, J=6.5Hz, 2H), 2.37(s, 3H). 13 CNMR(100MHz, CDCl 3 ): δppm 143.4, 137.2, 133.1, 132.0, 131.6, 129.7, 127.2, 126.9, 123.2, 122.9, 121.5, 89.9, 88.1, 47.6, 21.5. HRMS (ESI): Calculated for C 18 H 16 BrNO 2 S [M+Na] + : 411.9977, detected value: 412.0024.

Figure BDA00002102138700114
Figure BDA00002102138700114

收率:89%.1H NMR(400MHz,CDCl3):δppm 8.21(d,J=8Hz,1H),7.91(s,1H),7.65(d,J=8.4Hz,2H),7.25-7.18(m,2H),7.16-7.14(m,2H),5.42(d,J=0.4Hz,1H),5.37(d,J=1.2Hz,1H),5.18(br,1H),3.62(d,J=6.4Hz,2H),2.29(s,3H),2.13(s,3H).13C NMR(100MHz,CDCl3):δppm169.0,143.7,139.1,136.9,132.1,129.9,129.8,127.2,127.0,124.0,123.2,120.0,111.8,93.6,86.5,48.2,24.8,21.5.HRMS(ESI):计算值C20H20N2O3S[M+Na]+:391.1087,检测值:391.1105。Yield: 89%. 1 H NMR (400MHz, CDCl 3 ): δppm 8.21(d, J=8Hz, 1H), 7.91(s, 1H), 7.65(d, J=8.4Hz, 2H), 7.25-7.18 (m, 2H), 7.16-7.14(m, 2H), 5.42(d, J=0.4Hz, 1H), 5.37(d, J=1.2Hz, 1H), 5.18(br, 1H), 3.62(d, J=6.4Hz, 2H), 2.29(s, 3H), 2.13(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 169.0, 143.7, 139.1, 136.9, 132.1, 129.9, 129.8, 127.2, 127.0, 124.0, 123.2, 120.0, 111.8 , 93.6, 86.5, 48.2 , 24.8 , 21.5. HRMS (ESI): Calcd. for C20H20N2O3S [M+Na] + : 391.1087, found: 391.1105.

Figure BDA00002102138700121
Figure BDA00002102138700121

收率:72%.1H NMR(400MHz,CDCl3):δppm 7.78(d,J=8.4Hz,1H),7.49(s,1H),7.45(d,J=8.0Hz,1H),7.30-7.26(m,3H),7.16(t,J=7.9Hz,1H),5.50(s,1H),5.48(s,1H),5.17(br,1H),3.75(d,J=6.4Hz,2H),2.39(s,3H).13C NMR(100MHz,CDCl3):δppm 143.5,137.1,134.3,131.7,130.2,129.8,129.7,127.2,126.7,124.5,123.6,122.1,89.4,88.1,47.7,21.5.HRMS(ESI):计算值C18H16BrNO2S[M+Na]+:411.9977,检测值:412.0013。Yield: 72%. 1 H NMR (400MHz, CDCl 3 ): δppm 7.78(d, J=8.4Hz, 1H), 7.49(s, 1H), 7.45(d, J=8.0Hz, 1H), 7.30- 7.26(m, 3H), 7.16(t, J=7.9Hz, 1H), 5.50(s, 1H), 5.48(s, 1H), 5.17(br, 1H), 3.75(d, J=6.4Hz, 2H ), 2.39(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δppm 143.5, 137.1, 134.3, 131.7, 130.2, 129.8, 129.7, 127.2, 126.7, 124.5, 123.6, 122.1, 89.4, 88.1, 47.7, 21.5. HRMS (ESI): Calcd. for C18H16BrNO2S [M+Na] + : 411.9977 , found : 412.0013.

Figure BDA00002102138700122
Figure BDA00002102138700122

收率:68%.1H NMR(500MHz,CDCl3):δppm 8.15(d,J=8.1Hz,1H),7.79(d,J=8.0Hz,2H),7.73(s,1H),7.57(d,J=7.8Hz,1H),7.39(t,J=7.8Hz,1H),7.31-7.27(m,2H),5.50(s,1H),5.47(s,1H),4.77(br,1H),3.81(d,J=6.0Hz,2H),2.38(s,3H),1.68(s,9H).13C NMR(125MHz,CDCl3):δppm 148.8,143.3,137.0,130.0,129.5,129.0,127.2,127.0,126.9,125.2,123.2,122.4,120.0,115.1,102.6,90.3,84.4,83.1,47.7,28.0,21.3.HRMS(ESI):计算值C25H26N2O48[M+Na]+:473.1505,检测值:473.1494.。Yield: 68%. 1 H NMR (500MHz, CDCl 3 ): δppm 8.15(d, J=8.1Hz, 1H), 7.79(d, J=8.0Hz, 2H), 7.73(s, 1H), 7.57( d, J=7.8Hz, 1H), 7.39(t, J=7.8Hz, 1H), 7.31-7.27(m, 2H), 5.50(s, 1H), 5.47(s, 1H), 4.77(br, 1H ), 3.81 (d, J=6.0Hz, 2H), 2.38 (s, 3H), 1.68 (s, 9H). 13 C NMR (125MHz, CDCl 3 ): δppm 148.8, 143.3, 137.0, 130.0, 129.5, 129.0 , 127.2, 127.0, 126.9, 125.2, 123.2, 122.4, 120.0, 115.1, 102.6, 90.3, 84.4, 83.1, 47.7, 28.0, 21.3. HRMS (ESI): Calculated for C 25 H 26 N 2 O 48 [M+Na ] + : 473.1505, detected value: 473.1494..

以上所述仅为本发明的较佳实施例,并非用来限定本发明的实施范围。任何所属技术领域中具有通常知识者,在不脱离本发明的精神和范围内,当可作各种变动与润饰,本发明保护范围应以权利要求书所界定的保护范围为准。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the implementation scope of the present invention. Anyone with ordinary knowledge in the technical field may make various changes and modifications without departing from the spirit and scope of the present invention, and the protection scope of the present invention shall be determined by the protection scope defined in the claims.

Claims (7)

1. the preparation method of an arylalkyne ene compound, is characterized in that, take arylalkyne compounds and propargyl alcohol or propargylamine compounds as raw material, with [Rh (COD) Cl] 2The rhodium complex that generates with the part effect is catalyzer, and in organic solvent, reaction obtains the described arylalkyne ene compound shown in formula (I);
Described preparation method's reaction scheme is as with as shown in following formula (A):
Figure FDA00002102138600011
Wherein, R 1For hydrogen, methoxyl group, carboxaldehyde radicals, nitro, bromine, amino or-NHAc;
R 2For-OH or-NHTs.
2. preparation method as claimed in claim 1, is characterized in that, described arylalkyne compounds: propargyl alcohol or propargylamine compounds: [Rh (COD) Cl] 2: the mol ratio of part is 1: 1-1.5: 0.05: 0.2-0.3.
3. preparation method as claimed in claim 1, is characterized in that, described part is:
Figure FDA00002102138600012
Figure FDA00002102138600013
4. preparation method as claimed in claim 1, is characterized in that, described part is:
Figure FDA00002102138600014
5. preparation method as claimed in claim 1, is characterized in that, described organic solvent is methylene dichloride, trichloromethane, tetrahydrofuran (THF) or 1,2-ethylene dichloride.
6. preparation method as claimed in claim 1, is characterized in that, the described reaction times is 10-12 hour.
7. preparation method as claimed in claim 1, is characterized in that, described temperature of reaction is 25 ℃ to 40 ℃.
CN201210326046.3A 2012-09-05 2012-09-05 Preparation method of aryl eneyne compound Expired - Fee Related CN103102228B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210326046.3A CN103102228B (en) 2012-09-05 2012-09-05 Preparation method of aryl eneyne compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210326046.3A CN103102228B (en) 2012-09-05 2012-09-05 Preparation method of aryl eneyne compound

Publications (2)

Publication Number Publication Date
CN103102228A true CN103102228A (en) 2013-05-15
CN103102228B CN103102228B (en) 2014-07-16

Family

ID=48310466

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210326046.3A Expired - Fee Related CN103102228B (en) 2012-09-05 2012-09-05 Preparation method of aryl eneyne compound

Country Status (1)

Country Link
CN (1) CN103102228B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113354511A (en) * 2021-06-09 2021-09-07 湖南第一师范学院 Synthesis method of gem-1, 3-eneyne compound
CN116284696A (en) * 2023-03-03 2023-06-23 苏州大学 Polyaryleneyne as well as preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1187485A (en) * 1997-01-06 1998-07-15 美国氰胺公司 Aryne intermediates and process for preparation thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1187485A (en) * 1997-01-06 1998-07-15 美国氰胺公司 Aryne intermediates and process for preparation thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BUNRIT, A., S. RUCHIRAWAT, ET AL: "A simple microwave-assisted preparation of 2-bromo-1-alkenes from 1-alkynes using the LiBr–TMSCl–TEAB reagent system", 《TETRAHEDRON LETTERS》 *
HASHMI, A. S. K., T. HFFNER, ET AL.: "Cyclization of 2-Alkynylallyl Alcohols to Highly Substituted Furans by Gold(I)–Carbene Complexes.", 《EUROPEAN JOURNAL OF ORGANIC CHEMISTRY》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113354511A (en) * 2021-06-09 2021-09-07 湖南第一师范学院 Synthesis method of gem-1, 3-eneyne compound
CN116284696A (en) * 2023-03-03 2023-06-23 苏州大学 Polyaryleneyne as well as preparation method and application thereof
CN116284696B (en) * 2023-03-03 2024-08-16 苏州大学 A kind of polyaryl olefinyne and its preparation method and application

Also Published As

Publication number Publication date
CN103102228B (en) 2014-07-16

Similar Documents

Publication Publication Date Title
CN103554050B (en) A kind of synthetic method of benzoxazole compound
CN101798279B (en) Method for preparing iron-catalyzed pyrrole and pyrrole cyclic compounds
CN107935812B (en) Method for preparing polyaryl substituted naphthalene derivative by reaction of alkyl aryl ketone and tolane under catalysis of ruthenium
CN102584509B (en) Preparation method of amide
CN105585473A (en) Method for preparing propiolic acid compounds
CN102424645A (en) Method for synthesizing aromatic amide and aromatic methanol
CN103467300B (en) A kind of synthetic method of o-nitrobenzaldehyde compounds
CN102942511B (en) A kind of preparation method of cyclopentadiene
CN103102228B (en) Preparation method of aryl eneyne compound
CN113387886B (en) A kind of 2-aminodibenzo[c,e]azepine compound and synthetic method thereof
CN112225668B (en) A kind of synthesis method of α-alkylglycine compounds
CN103275027B (en) Synthesis method of alpha-keto amide compound
CN102558095B (en) Method for preparing aromatic amine compound
CN109912492B (en) Synthetic method of 3-benzylidene isoindoline-1-one derivative
CN103864567B (en) A kind of preparation method of biaryl compound
CN113354500B (en) A method for preparing 1,5-diene derivatives
CN106892826A (en) A kind of preparation method and application of amine and imines N-methyl
CN108383755B (en) Method for synthesizing alkene dinitrile compound
CN113105301B (en) Method for preparing conjugated diyne compound by using copper complex
CN115232163A (en) A kind of silicon center chiral molecular compound and its preparation method and application
CN111018779B (en) 2- (3-isoquinolyl) -ethyl propionate derivative and synthetic method thereof
CN102731386B (en) Preparation method of para-diimide derivative
CN112574107B (en) Synthesis method of atropisomeric 1-arylisoquinoline N-oxide and derivatives thereof
CN110368989A (en) A kind of application of palladium complex in fatty amine formylation reaction
CN108727179A (en) A kind of alpha, beta-unsaturated ketone of α-allyl substitution, the synthetic method of ester or nitrile compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140716

Termination date: 20170905